162 related articles for article (PubMed ID: 18217963)
1. Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review.
Yeasmin S; Nakayama K; Ishibashi M; Oride A; Katagiri A; Purwana IN; Iida K; Nakayama N; Ishikura H; Miyazaki K
Int J Gynecol Cancer; 2008; 18(6):1371-6. PubMed ID: 18217963
[TBL] [Abstract][Full Text] [Related]
2. [Secondary myelodysplasia and leukemia following carboplatin and paclitaxel-containing chemotherapy for ovarian cancer].
Abe A; Ikawa H; Muguruma H; Maeda Y
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1795-8. PubMed ID: 18931592
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Nakayama N; Miyazaki K
Eur J Gynaecol Oncol; 2014; 35(4):443-8. PubMed ID: 25118489
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related myelodysplastic syndrome with trisomy 1q due to der(1;7) and megakaryoblastic proliferation developing during complete remission of therapy-related acute myeloid leukemia with t(8;21).
Sakai C; Matsubayashi K; Saotome T; Ishii A; Kumagai K
Intern Med; 2004 Jul; 43(7):582-6. PubMed ID: 15335185
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Myelodysplastic Syndrome Developed during Chemotherapy for Postoperative Recurrent Ovarian Cancer That Progressed to Acute Myeloid Leukemia].
Abe R; Murakami M; Okajima S; Suruga M; Nagatsuji M; Kawanishi M; Tokuyama O; Yamane T; Kawamura N
Gan To Kagaku Ryoho; 2023 Jul; 50(7):821-824. PubMed ID: 37496229
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
7. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).
Sakugawa M; Kojima K; Kaneda K; Masuda K; Dansako H; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M; Tanimoto M
Ann Hematol; 2001 Dec; 80(12):763-6. PubMed ID: 11797121
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Rose PG; Rodriguez M; Waggoner S; Greer BE; Horowitz IR; Fowler JM; McGuire WP
J Clin Oncol; 2000 Aug; 18(16):2957-62. PubMed ID: 10944128
[TBL] [Abstract][Full Text] [Related]
11. Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer.
Colon-Otero G; Malkasian GD; Edmonson JH
J Natl Cancer Inst; 1993 Nov; 85(22):1858-60. PubMed ID: 8230267
[No Abstract] [Full Text] [Related]
12. Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan.
Nakamura Y; Kamei T; Shinagawa M; Sakamoto Y; Miwa I
J Obstet Gynaecol Res; 2015 May; 41(5):809-12. PubMed ID: 25511544
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X
Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742
[No Abstract] [Full Text] [Related]
14. Case report of isochromosome 17q in acute myeloid leukemia with myelodysplasia-related changes after treatment with a hypomethylating agent.
Sousa JC; Germano RT; Castro CC; Magalhaes SM; Pinheiro RF
Genet Mol Res; 2012 Aug; 11(3):2045-50. PubMed ID: 22911588
[TBL] [Abstract][Full Text] [Related]
15. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
[TBL] [Abstract][Full Text] [Related]
16. Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB.
Griesinger F; Metz M; Trümper L; Schulz T; Haase D
Lung Cancer; 2004 May; 44(2):261-5. PubMed ID: 15084391
[TBL] [Abstract][Full Text] [Related]
17. [A case of therapy-related acute myeloid leukemia associated with inv(16)].
Lee SY; Kim M; Lim J; Kim Y; Han K; Kim SY; Kim HJ; Park IY
Korean J Lab Med; 2007 Feb; 27(1):19-21. PubMed ID: 18094545
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
[TBL] [Abstract][Full Text] [Related]
19. Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer.
See HT; Thomas DA; Bueso-Ramos C; Kavanagh J
Int J Gynecol Cancer; 2006; 16 Suppl 1():236-40. PubMed ID: 16515597
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents.
Bennett JM; Moloney WC; Greene MH; Boice JD
Hematol Pathol; 1987; 1(2):99-104. PubMed ID: 3504435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
